KA/EN
Register
Medicines reference
Search
Search
Product

Bavet Meloxicam

Favourites

Meloxicam · Arion İlaç San. Tic. A.Ş.

1 form: solution. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Dose Frequency Georgia
5 mg/ml solution for injection, Solution · Cat Cat Postoperative Pain · Subcutaneous: 0.3 mg/kg - Georgia Yes, veterinary
In force until 19 Mar 2029
Veterinary (National Food Agency)
In the register: ბავეტ მელოქსიკამი
№ 000630
Verified on: 21 Oct 2026
5 mg/ml solution for injection, Solution · Dog Dog Musculoskeletal Pain and Inflammation · Subcutaneous: 0.2 mg/kgPostoperative Pain · Subcutaneous: 0.2 mg/kgPostoperative Pain · Intravenous: 0.2 mg/kg - Georgia Yes, veterinary
In force until 19 Mar 2029
Veterinary (National Food Agency)
In the register: ბავეტ მელოქსიკამი
№ 000630
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Bavet Meloxicam 5 mg/ml solution for injection, Solution

100 ml for cattle, dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Dog label: a single 0.2 mg/kg SC or IV dose for perioperative pain, or SC for acute or chronic musculoskeletal pain and inflammation, with oral meloxicam follow-up after 24 hours where indicated
6.2/10
Situational / acceptable
vetman assessment

Bavet Meloxicam

5 mg/ml solution for injection, 100 ml for cattle, dogs and cats
Assessed clinical scopeDog · Dog label: a single 0.2 mg/kg SC or IV dose for perioperative pain, or SC for acute or chronic musculoskeletal pain and inflammation, with oral meloxicam follow-up after 24 hours where indicated · SC,IV
Care settingClinic injection in a hydrated, normotensive dog with normal kidney and liver function, usually at anaesthetic induction or the first visit
vetman score 6.2/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 000630 · Verified on 21 Oct 2026

A situational generic meloxicam injection: the drug is a proven analgesic, but product equivalence is unverified and the 100 ml cattle-sized vial is impractical for small-animal work. An EU-authorised small-volume meloxicam or robenacoxib injection is preferable.

Regulatory and scientific credibility5.0/10

The exact 100 ml vial is registered in Georgia (000630, valid to 2029) with a current Turkish manufacturer label whose dog and cat doses mirror the EU reference (Metacam), but it has no EU, UK or US authorisation documented in the reviewed evidence and no public bioequivalence data.

Clinical efficacy7.0/10

Meloxicam 0.2 mg/kg is a well-proven perioperative and musculoskeletal analgesic in dogs and is supported by pain guidelines; the formulation's equivalence to the reference is assumed, not shown.

Safety and tolerability6.5/10

NSAID risks are real: the label excludes dogs under 6 weeks, pregnant or lactating, dehydrated or hypotensive dogs, and liver, heart, kidney, bleeding or gastrointestinal disease, and bans combination with glucocorticoids, other NSAIDs or anticoagulants.

Clinical practicality6.5/10

At 0.04 ml/kg a single injection is easy to draw up, but a 100 ml multi-species vial is far more than a small-animal clinic usually uses, so expect long storage or discard after broaching.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in dehydrated, hypovolaemic or hypotensive dogs, in pregnancy or lactation, under 6 weeks, or with liver, heart, kidney, bleeding or gastrointestinal disease.
  • Do not combine with glucocorticoids, other NSAIDs or anticoagulants; avoid nephrotoxic drugs and allow a washout when switching NSAIDs.
  • Support blood pressure and fluids under anaesthesia, and check kidney values before use in older dogs.
  • One injection only; continue after 24 hours with an oral veterinary meloxicam product if needed.
  • The same vial is labelled for cattle; record the broach date and keep to the labelled in-use period.
Assessment sources
  1. Bavet Meloxicam
  2. Georgia NFA register 20262026
  3. EMA Metacam EPAR2024
  4. WSAVA pain guideline2023
  5. AAHA Pain Guidelines 20222022
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Cat label: a single 0.3 mg/kg SC dose before surgery for postoperative pain, with no oral meloxicam follow-up
5.6/10
Weak evidence support
vetman assessment

Bavet Meloxicam

5 mg/ml solution for injection, 100 ml for cattle, dogs and cats
Assessed clinical scopeCat · Cat label: a single 0.3 mg/kg SC dose before surgery for postoperative pain, with no oral meloxicam follow-up · Subcutaneous
Care settingClinic injection at anaesthetic induction in a hydrated, normotensive cat over 2 kg and 6 weeks with normal kidney function
vetman score 5.6/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000630 · Verified on 21 Oct 2026

A weak option for cats: meloxicam works, but the tiny dose volume from a concentrated 100 ml multi-species vial invites overdose. Use a cat-sized EU-authorised meloxicam or robenacoxib product where available.

Regulatory and scientific credibility5.0/10

The exact 100 ml vial is registered in Georgia (000630, valid to 2029) with a current Turkish manufacturer label whose dog and cat doses mirror the EU reference (Metacam), but it has no EU, UK or US authorisation documented in the reviewed evidence and no public bioequivalence data.

Clinical efficacy6.5/10

A single 0.3 mg/kg meloxicam dose before surgery is a proven postoperative analgesic in cats; equivalence of this formulation to the reference is assumed, not shown.

Safety and tolerability5.5/10

Cats are sensitive to NSAIDs and kidney risk rises with dehydration or hypotension under anaesthesia; at 5 mg/ml the dose is only 0.06 ml/kg, so a small measuring error becomes a large overdose.

Clinical practicality5.5/10

A 4 kg cat needs 0.24 ml, which requires an insulin or 1 ml syringe, and the 100 ml cattle-sized vial is poorly suited to feline practice.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use under 2 kg or 6 weeks, in pregnancy or lactation, or with liver, heart, kidney, bleeding or gastrointestinal disease; avoid dehydration and hypotension.
  • Measure 0.06 ml/kg with an insulin or 1 ml syringe; never estimate the volume.
  • Do not follow with oral meloxicam or another NSAID, and do not combine with glucocorticoids.
  • Give IV fluids and monitor blood pressure under anaesthesia; check kidney values in older cats.
  • The same vial is labelled for cattle; record the broach date and keep to the labelled in-use period.
Assessment sources
  1. Bavet Meloxicam
  2. Georgia NFA register 20262026
  3. EMA Metacam EPAR2024
  4. WSAVA pain guideline2023
  5. AAHA Pain Guidelines 20222022
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Meloxicam5 mg/ml
Formulation Type
Solution
Administration route
Subcutaneous, Intravenous, Intramuscular
Manufacturer (register)
ARION Ilac San. Tic. A.S, Türkiye
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1023, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 19 Mar 2029
Veterinary (National Food Agency)
In the register: ბავეტ მელოქსიკამი
№ 000630
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Cat
WeightPostoperative Pain · Subcutaneous
Any weight 0.3 mg/kg
  • Postoperative Pain · Subcutaneous (once before surgery): Give one subcutaneous injection before surgery, for example during induction of anaesthesia. Measure accurately: at 5 mg/ml the volume is 0.06 ml/kg. Do not use below 2 kg or 6 weeks, during pregnancy or lactation, or with hepatic, cardiac, renal, haemorrhagic or gastrointestinal disease. Avoid dehydrated, hypovolaemic or hypotensive patients. Do not continue with oral meloxicam or another NSAID because an oral follow-up dose is not established for cats.
Source:
Bavet Meloxicam
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Bavet Meloxicam 5 mg/ml solution for injection - current official product instruction
Bavet official veterinary product instruction
Dog
WeightMusculoskeletal Pain and Inflammation · SubcutaneousPostoperative Pain · SubcutaneousPostoperative Pain · Intravenous
Any weight 0.2 mg/kg 0.2 mg/kg 0.2 mg/kg
  • Musculoskeletal Pain and Inflammation · Subcutaneous (once): For acute or chronic musculoskeletal inflammation and pain, give one subcutaneous injection. Treatment may be continued 24 hours later only with an appropriate oral veterinary meloxicam presentation. Do not use under 6 weeks, during pregnancy or lactation, or with hepatic, cardiac, renal, haemorrhagic or gastrointestinal disease. Avoid dehydrated, hypovolaemic or hypotensive patients. Do not combine with a glucocorticoid, another NSAID or an anticoagulant; avoid potentially nephrotoxic medicines.
  • Postoperative Pain · Subcutaneous (once before surgery): Give one subcutaneous injection before surgery, for example during induction of anaesthesia. Observe the same age, reproductive, organ-disease, hydration and interaction restrictions stated for this product.
  • Postoperative Pain · Intravenous (once before surgery): Give one intravenous injection before surgery, for example during induction of anaesthesia. Observe the same age, reproductive, organ-disease, hydration and interaction restrictions stated for this product.
Source:
Bavet Meloxicam
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Bavet Meloxicam 5 mg/ml solution for injection - current official product instruction
Bavet official veterinary product instruction
Active substance doses, with sources
Active substance Meloxicam
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
0.1 mg/kg Dog Maintenance By mouth once daily
Source: EMA UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
MELOXICAM Bioveta 1.5 mg/ml oral suspension for dogs - SPC (Czech Republic)
EU Union Product Database, 2026
0.2 mg/kg Dog Inflammation Subcutaneous once
Norbrook Meloxicam, VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Norbrook Meloxicam 5 mg/ml Solution for Injection for Dogs and Cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024
0.2 mg/kg Dog Loading By mouth once, day 1
Source: EMA UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
MELOXICAM Bioveta 1.5 mg/ml oral suspension for dogs - SPC (Czech Republic)
EU Union Product Database, 2026
0.2 mg/kg Dog Inflammation
Premedication
 Intravenous once
Norbrook Meloxicam, VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Norbrook Meloxicam 5 mg/ml Solution for Injection for Dogs and Cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024
0.3 mg/kg Cat Inflammation Subcutaneous once
Norbrook Meloxicam, VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Norbrook Meloxicam 5 mg/ml Solution for Injection for Dogs and Cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024

Known Contraindications

  • Critical
    Do not use in animals suffering from... impaired hepatic, cardiac or renal function
    Sources: VMD SPC · VMD
  • Critical
    Do not use meloxicam in animals with impaired cardiac function.
    Sources: VMD SPC · VMD
  • Critical
    Do not use in animals suffering from... haemorrhagic disorders.
    Sources: VMD SPC · VMD
  • Critical
    Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity.
    Sources: VMD SPC · VMD
  • Critical
    Hepatic impairment is a contraindication.
    Sources: VMD SPC · VMD
  • Critical
    Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage
    Sources: VMD SPC · VMD
  • Critical
    Do not use meloxicam during pregnancy.
    Sources: VMD SPC · VMD
  • Critical
    Do not use meloxicam during lactation.
    Sources: VMD SPC · VMD
  • Critical
    Known hypersensitivity to meloxicam or any excipient is a contraindication.
    Sources: VMD SPC · VMD
  • Critical
    Do not use in animals less than 6 weeks of age
    Sources: VMD SPC · VMD
  • Critical (Cat)
    USA (FDA label, Metacam injection): cats get one injection only, 0.3 mg/kg under the skin. The boxed warning links repeated meloxicam in cats with acute kidney failure and death; give no further meloxicam or other NSAID after it. The US oral suspension is labelled for dogs only.
    Sources: FDA
  • Warning
    Avoid use in any dehydrated, hypovolaemic or hypotensive animal
    Sources: VMD SPC · VMD
  • Warning (Cat)
    Do not use in animals less than 6 weeks of age nor in cats of less than 2 kg.
    Sources: VMD SPC · VMD
  • Warning (Cat)
    Cats (EU label, Metacam): the injection is one dose before surgery. Oral meloxicam after surgery (0.05 mg/kg once daily) may follow for at most 4 days, 5 days in all. For acute musculoskeletal pain the oral dose continues only while the acute pain lasts; for chronic disease it is a long-term 0.05 mg/kg daily dose with regular review, stopped after 14 days if there is no improvement. Do not give cats a dog formulation.
    Source: EMA Sources: EMA · EU UPD

Known Drug Interactions

  • Contraindicated Meloxicam + Prednisolone
    Concomitant use of corticosteroids and non-steroidal anti-inflammatory drugs can worsen gastrointestinal ulceration.
    Recommendation: Do not administer together. Observe an appropriate washout period when switching and monitor for melena, vomiting, and reduced appetite.
    Sources: Product label
  • Contraindicated Meloxicam + Robenacoxib
    Do not give robenacoxib together with other non-steroidal anti-inflammatory drugs or glucocorticoids because adverse gastrointestinal and renal effects may increase.
    Recommendation: Do not use these drugs together. Allow a treatment-free interval of at least 24 hours after the previous anti-inflammatory drug, extending it when required by that drug’s pharmacokinetics.
  • Major warning Meloxicam + Carprofen
    Do not give other non-steroidal anti-inflammatory drugs or glucocorticoids concurrently with carprofen or within 24 hours of treatment because gastrointestinal ulceration or perforation may occur.
    Recommendation: Consider appropriate washout times when switching from one NSAID to another or when switching from corticosteroid use to NSAID use.
    Sources: FDA
  • Major warning Meloxicam + Dexamethasone
    The concomitant use of this veterinary medicinal product with non-steroidal anti-inflammatory drugs may exacerbate gastrointestinal tract ulceration.
    Recommendation: Avoid concurrent administration. Observe an appropriate washout period when switching. If both are essential, provide gastroprotection and monitor gastrointestinal signs closely.
    Sources: VMD SPC · VMD

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (4 more) Hide additional products

Same therapeutic group 4

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗